Canine Immune-Mediated Skin Disease Study Guide

Overview and Clinical Importance

Immune-mediated skin diseases (IMSDs) represent a group of conditions in which the body's immune system inappropriately targets components of the skin. These diseases occur when autoantibodies attack structural proteins of the epidermis (pemphigus), the basement membrane zone (subepidermal blistering diseases), or components at the dermoepidermal junction (lupus erythematosus). While individually uncommon, these conditions represent significant board examination topics because they require systematic diagnostic approaches, careful histopathological interpretation, and complex long-term immunosuppressive management.

Understanding the pathophysiology, clinical presentation, and treatment of these diseases is essential for the NAVLE. Key concepts include recognizing the characteristic lesion distributions, understanding which diagnostic tests to pursue, and knowing when to initiate immunosuppressive therapy versus treating for more common conditions like bacterial pyoderma.

Section 1: The Pemphigus Complex

The pemphigus complex is a group of autoimmune dermatoses characterized by acantholysis - the loss of intercellular adhesion between keratinocytes caused by autoantibodies targeting desmosomal proteins. The level of acantholysis within the epidermis determines the specific pemphigus variant and correlates with clinical severity.

Pemphigus Foliaceus (PF)

Overview and Pathophysiology

Pemphigus foliaceus is the most common autoimmune skin disease in dogs, accounting for approximately one-third of all canine autoimmune dermatoses. In dogs, the primary autoantigen is desmocollin-1 (Dsc1), which differs from human pemphigus foliaceus where desmoglein-1 is the target. Autoantibodies directed against Dsc1 cause loss of keratinocyte adhesion in the superficial epidermis (stratum granulosum and stratum spinosum), resulting in subcorneal pustule formation.

The disease may be idiopathic (spontaneous) or drug-induced. Known triggers include certain antibiotics (particularly sulfonamides and cephalosporins), topical flea/tick products containing metaflumizone or fipronil-amitraz combinations, and chronic allergic skin disease. UV light exposure may exacerbate clinical signs.

Breed Predispositions

Clinical Signs and Lesion Distribution

Pemphigus foliaceus typically affects middle-aged dogs (average age 4-5 years), though any age can be affected. The onset may be acute or insidious, and the disease characteristically follows a waxing and waning course.

Primary Lesions:

• Large, superficial pustules spanning multiple hair follicles - this is the hallmark lesion
• Pustules are thin-walled, fragile, and rupture rapidly (often not observed on examination)
• Contents appear translucent to yellowish

Secondary Lesions:

• Yellow-brown adherent crusts (most commonly seen on examination)
• Erosions, alopecia, and epidermal collarettes
• Footpad hyperkeratosis, fissuring, and crusting

Classic Distribution Pattern (Butterfly Pattern):

• Nasal planum and dorsal muzzle - most commonly affected
• Periocular regions - symmetric involvement
• Pinnae - both concave and convex surfaces, including margins
• Footpads - hyperkeratotic, cracked, painful - important differentiator from DLE
• May generalize to trunk, groin, and nail beds

Systemic Signs (in severe cases):

• Depression, anorexia, fever, weight loss
• Lymphadenopathy
• Variable pruritus and pain

Diagnosis

Cytology (Tzanck Preparation): Impression smears from intact pustules or undersurface of crusts provide valuable preliminary information.

• Acantholytic keratinocytes - round, nucleated cells with basophilic cytoplasm, often in rafts or clusters (fried egg appearance)
• Nondegenerate neutrophils surrounding the acantholytic cells
• Absence of bacteria (helps differentiate from bacterial pyoderma)
• Occasional eosinophils may be present

Histopathology (Gold Standard): Skin biopsy is required for definitive diagnosis.

• Subcorneal pustules containing acantholytic keratinocytes - hallmark finding
• Pustules often span multiple hair follicles
• Neutrophilic (and sometimes eosinophilic) inflammation within pustules
• Layering of acantholytic cells may be observed

Treatment of Pemphigus Foliaceus

The goal of treatment is to achieve remission (absence of active lesions) with the lowest effective dose of immunosuppressive medication. The approach is hit hard, then back off - induce remission rapidly, then taper to minimize side effects.

Section 2: Discoid Lupus Erythematosus (DLE)

Overview and Pathophysiology

Discoid lupus erythematosus is the second most common autoimmune skin disease in dogs. DLE is a benign, skin-confined form of lupus that does NOT progress to systemic lupus erythematosus (SLE). Autoantibodies target components of the basement membrane zone, causing interface dermatitis with vacuolar degeneration at the dermoepidermal junction.

UV Light Sensitivity: Clinical signs often worsen in summer and improve in winter. Sun avoidance is a critical part of treatment.

Breed Predispositions

• German Shepherd Dog - most commonly affected
• Collie and Shetland Sheepdog
• Siberian Husky, Alaskan Malamute
• Brittany Spaniel

Clinical Signs

The nasal planum is almost always the first and primary site affected.

Early Signs:

• Loss of the normal cobblestone texture - nose becomes smooth
• Depigmentation - black nose becomes slate-gray or pink
• Erythema of the nasal planum

Progressive Signs:

• Crusting, scaling, erosions, and ulcers
• Extension up the dorsal muzzle
• May involve lips, periocular area, pinnae

Diagnosis

• Histopathology: Interface dermatitis with vacuolar degeneration of basal keratinocytes, lichenoid lymphoplasmacytic infiltrate
• ANA: Typically NEGATIVE (positive ANA suggests SLE)
• Important: Rule out mucocutaneous pyoderma (MCP) first - treat with antibiotics for 4-6 weeks

Treatment

Prognosis: Good. DLE does NOT progress to SLE. Most cases controlled with topical therapy. Long-term concern: chronic DLE may predispose to squamous cell carcinoma of the nasal planum.

Section 3: Systemic Lupus Erythematosus (SLE)

Systemic lupus erythematosus is a rare, multisystemic autoimmune disease with autoantibodies against nuclear components (DNA, RNA, histones). Immune complexes deposit in various tissues causing inflammation. SLE can affect virtually any organ system.

Breed Predispositions

• German Shepherd Dog, Shetland Sheepdog, Collie, Old English Sheepdog
• Beagle, Afghan Hound, Irish Setter, Poodle
• Nova Scotia Duck Tolling Retriever (genetic predisposition documented)

Clinical Signs

Diagnosis

Requires positive ANA PLUS at least 2 major criteria:

• Polyarthritis (non-erosive)
• Glomerulonephritis
• Immune-mediated hemolytic anemia or thrombocytopenia
• Characteristic skin lesions with interface dermatitis
• Polymyositis

Treatment: High-dose glucocorticoids (2-4 mg/kg/day) plus steroid-sparing agents. Supportive care based on affected organs. Prognosis: Guarded to poor. Approximately 40% die or are euthanized in the first year.